A UA research team studying the anti-inflammatory impact of turmeric is moving the project out of the laboratory and into patient testing. (Source)Continue reading→

Life science entrepreneur, investor,and philanthropist Peter N. Allison passed away unexpectedly in Scottsdale, AZ  on December 22, 2015.Continue reading→

Partnership Would Combine Company’s Patented Technology that Detects Pre-cancer of the Lungs with Drug Treatment that Prevents Cancer Continue reading→

TGen continues to grow as an economic engine for Arizona, creating high-paying jobs, state revenues and significant return on investment.  Report documents TGen’s $174 million in total annual economic impact, while also attracting research dollars and advancing precision medicineContinue reading→

SenesTech, Inc., an Arizona based life science company, today announced a series of significant changes and additions to its management team and board of directors. The Company believes the changes and additions to its team will help position it to commercialize its lead product candidate, ContraPest. ContraPest is an innovative technology for managing rodent pest populations through fertility as opposed to a lethal approach. SenesTech submitted ContraPest to the EPA for registration in 2015, and though there can be no assurance, the Company is hopeful of obtaining a positive determination in 2016.Continue reading→

8-week paid summer program pairs students with TGen researchers in significant efforts to benefit patientsContinue reading→

The licensed technology can increase global access to gene therapy through lower costs and shortened regulatory timelinesContinue reading→

Colorectal cancer biotech Cancer Prevention Pharmaceuticals files for a $29 million IPOContinue reading→

Looking to give back before year end? Check out the AZBio Annual Giving GuideContinue reading→